Publications by authors named "Ruby Redmond-Misner"

Claim this Profile
R
Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis.
Kelvin K W Chan, Helen Guo, Sierra Cheng, Jaclyn M Beca, Ruby Redmond-Misner

Cancer Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are population-based patient-reported outcomes associated with overall survival in patients with advanced pancreatic cancer?
Wei Fang Dai, Jaclyn Beca, Helen Guo, Wanrudee Isaranawatchai, Deborah Schwartz, Ruby Redmond-Misner

Cancer Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis